Intra-Cellular Therapies Inc. buy Needham & Company LLC
Start price
18.06.24
/
50%
€71.00
Target price
18.06.25
€87.54
Performance (%)
-7.04%
Price
27.09.24
€66.00
Summary
This prediction is currently active. With a performance of -7.04%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 18.06.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -4.348% | -4.348% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Needham___Company_LL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Needham & Company LLC from $90.00 to $94.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Needham___Company_LL for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.50
22.07.24
22.07.24
€91.90
22.07.25
22.07.25
-5.04%
27.09.24
27.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
07.05.24
07.05.24
€83.49
07.05.25
07.05.25
3.13%
27.09.24
27.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€84.46
22.04.25
22.04.25
-6.38%
27.09.24
27.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
05.04.24
05.04.24
€75.83
05.04.25
05.04.25
3.13%
27.09.24
27.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
23.02.24
23.02.24
€75.68
23.02.25
23.02.25
3.94%
27.09.24
27.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.70
03.08.23
03.08.23
€66.63
03.08.24
03.08.24
27.56%
04.08.24
04.08.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24